Aristides Capital LLC Buys Shares of 824 CorVel Co. (NASDAQ:CRVL)

Aristides Capital LLC bought a new stake in shares of CorVel Co. (NASDAQ:CRVL) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 824 shares of the business services provider’s stock, valued at approximately $210,000.

Several other large investors also recently added to or reduced their stakes in the company. Corient Private Wealth LLC increased its stake in shares of CorVel by 30.0% in the fourth quarter. Corient Private Wealth LLC now owns 2,321 shares of the business services provider’s stock worth $574,000 after acquiring an additional 535 shares during the last quarter. Stifel Financial Corp increased its position in CorVel by 11.2% during the fourth quarter. Stifel Financial Corp now owns 26,661 shares of the business services provider’s stock worth $6,591,000 after buying an additional 2,679 shares during the last quarter. Campbell & CO Investment Adviser LLC boosted its holdings in CorVel by 76.6% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 3,186 shares of the business services provider’s stock valued at $788,000 after acquiring an additional 1,382 shares during the period. 1832 Asset Management L.P. boosted its holdings in CorVel by 112.9% during the fourth quarter. 1832 Asset Management L.P. now owns 1,703 shares of the business services provider’s stock valued at $421,000 after acquiring an additional 903 shares during the period. Finally, Quadrature Capital Ltd bought a new stake in CorVel during the fourth quarter valued at about $887,000. 51.36% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CorVel

In related news, Director R Judd Jessup sold 2,500 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $311.60, for a total value of $779,000.00. Following the completion of the sale, the director now owns 40,777 shares in the company, valued at $12,706,113.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Mark E. Bertels sold 300 shares of the stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $299.80, for a total value of $89,940.00. Following the completion of the sale, the executive vice president now owns 858 shares in the company, valued at $257,228.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director R Judd Jessup sold 2,500 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $311.60, for a total transaction of $779,000.00. Following the completion of the sale, the director now owns 40,777 shares of the company’s stock, valued at approximately $12,706,113.20. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 72,431 shares of company stock worth $19,961,847. Company insiders own 47.57% of the company’s stock.

CorVel Price Performance

CRVL stock opened at $319.60 on Wednesday. CorVel Co. has a 52-week low of $187.92 and a 52-week high of $329.23. The company has a 50-day moving average of $310.61 and a two-hundred day moving average of $273.12. The stock has a market capitalization of $5.49 billion, a price-to-earnings ratio of 72.64 and a beta of 1.08.

CorVel (NASDAQ:CRVL) last released its quarterly earnings results on Tuesday, July 30th. The business services provider reported $1.25 earnings per share (EPS) for the quarter. CorVel had a net margin of 9.55% and a return on equity of 32.25%. The company had revenue of $211.72 million during the quarter.

Wall Street Analyst Weigh In

Separately, StockNews.com cut shares of CorVel from a “buy” rating to a “hold” rating in a report on Saturday, August 31st.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.